Omega-3s and AFib: The 1,500 mg Line That Changes Everything

For years, headlines have warned that omega-3 supplements might trigger atrial fibrillation, the most common type of irregular heartbeat. Now the biggest analysis ever done on the question says the scary part came down to two things: who was taking them, and how much. And there’s a clear dose line that separates “you’re fine” from “worth a chat with your doctor.”

Why this study hits different

The original AFib scare came from a handful of meta-analyses, each built on eight or fewer randomized trials. Worse, they often left out trials where AFib data existed but was never published — exactly the kind of gap that can skew the picture.

This new analysis, led by researchers at the Fatty Acid Research Institute and published in Circulation: Arrhythmia and Electrophysiology, went much bigger: 35 randomized controlled trials, 37 data sets, 114,592 participants. The team included 15 trials with previously unpublished AFib data, plus trials that recorded zero AFib events. That last move matters, because studies with “nothing happened” results rarely get published, and leaving them out can quietly inflate the apparent risk.

Worth knowing, for fairness: two of the senior authors report industry ties. One is the chief medical officer of a company that sells omega-3 products, and another holds stock in a fatty-acid testing lab. That’s no reason to dismiss the findings — the analysis is built on other people’s randomized trials, not their own products — but it’s good context.

What the numbers actually say

The researchers split everyone into four groups based on dose and background heart risk. Here’s the scoreboard, measured against people who took a placebo:

Two things to notice. First, “43% higher odds” sounds dramatic, but it’s a relative increase. The absolute bump was 0.8 percentage points — fewer than 1 extra case in 100. Both numbers are real; the absolute one tells you how much it actually matters.

Second, the authors put that bump in perspective: high-dose EPA has been linked in major clinical trials to fewer heart attacks and strokes. In their words, the AFib increase looked small next to those benefits. The takeaway isn’t “high-dose omega-3s are dangerous” — it’s that for high-risk patients on high doses, a little extra monitoring may be worth discussing with a doctor.

The supplement connection

So where do everyday fish oil bottles sit in all this? Here’s how the dose line maps to real products:

• Standard fish oil capsules: Typical nutritional products deliver roughly 500 to 1,500 mg of EPA + DHA per day. The study suggests these doses are not linked to a higher AFib risk.
• EPA + DHA (not just “fish oil”): Most labels list EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) separately. Add those two numbers together — that’s the figure this study is about, not the total milligrams of fish oil in the capsule.
• High-dose prescription omega-3s: Products dosed at 2 to 4 grams a day, usually prescribed for high triglycerides or established heart disease. This is the territory where the study found its signal — and exactly the situation to talk through with your doctor rather than adjusting on your own.
• The typical one-capsule-a-day habit: A single standard softgel usually delivers a few hundred milligrams of EPA + DHA, well under the 1,500 mg line. This study’s verdict on that habit is reassuring.

If you’re shopping for a fish oil, our review page breaks down the best omega-3 options available in Canada.

A quick note for Canadians

This one has genuine label-reading value at the pharmacy shelf. Canadian fish oil labels show the EPA and DHA content per capsule — add them up and compare against the 1,500 mg line, and look for the NPN (Natural Product Number) on the label, which confirms Health Canada has licensed the product. At a typical one- or two-capsule dose, most Canadians sit comfortably below the threshold this study flagged. If you take prescription-strength omega-3s or live with heart disease, this research is a good reason to loop your pharmacist or doctor into the conversation — not to quit anything on your own.

This article reports on recent health research and is for general information only — it isn’t medical advice and doesn’t replace your doctor, pharmacist, or another qualified professional. Study findings describe what researchers observed, not a promise of results, and nothing here claims any supplement can diagnose, treat, cure, or prevent a disease. These statements have not been evaluated by Health Canada. Check with a healthcare professional before starting any new supplement, especially if you’re pregnant, nursing, taking medication, or managing a health condition.